ProQR Therapeutics N. V. , a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders.
Proqr Therapeutics Nv stock last closed at $1.32, up 15.79% from the previous day, and has decreased 34% in one year. It has overperformed other stocks in the Biotechnology industry by 0.44 percentage points. Proqr Therapeutics Nv stock is currently +23.36% from its 52-week low of $1.07, and -71.43% from its 52-week high of $4.62.
There are currently 105.21M PRQR shares outstanding. The market value of PRQR is $138.88M. In the last 24 hours, 839,669 PRQR shares were traded.
How to Buy Proqr Therapeutics Nv Stock
Not sure how to invest in Proqr Therapeutics Nv stock? Here's how.
Figure out where to buy Proqr Therapeutics Nv stock: You need to pick an online brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you figure out where to buy Proqr Therapeutics Nv stock.
Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
Deposit money your brokerage account: Select your payment method and add your information.
Analyze Proqr Therapeutics Nv stock: The Proqr Therapeutics Nv ticker symbol is PRQR. Is Proqr Therapeutics Nv stock a good investment? Should you buy shares of PRQR? How do PRQR's underlying business fundamentals look? Do top analysts think Proqr Therapeutics Nv is a good buy? Why has PRQR's stock price moved recently? (Hint: Our stock market analysis website can help you figure out if PRQR is a good stock to buy).
Place your PRQR trade: Decide if you will purchase PRQR shares at the current market price or use a limit order to buy PRQR stock at a given price.
Keep tabs on your investment in PRQR: Create a watchlist to key updates about your new investment in Proqr Therapeutics Nv stock.
Step 1: Figure out where to buy Proqr Therapeutics Nv stock
You need a brokerage account to access the NASDAQ market and buy PRQR shares.
A brokerage account is an investment account that enables you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best place to buy stocks. eToro gives you:
You can invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
Access to world financial markets: From Technology to Industrials, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by opening an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've selected the best brokerage, it's time to fill out some personal information so you can invest in PRQR stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Proqr Therapeutics Nv stock
Once you have selected the best place to buy Proqr Therapeutics Nv stock, it's absolutely critical to evaluate their stock prior to investing, so you can wrap your head around the risk as well as the opportunity.
Proqr Therapeutics Nv shares quick numbers
PRQR Price
$1.32
1w %
11.86%
1y %
-34%
5y %
-74.57%
P/E
-3.79x
P/B
1.44x
P/S
5.34x
PEG
N/A
Revenue
$21.24M
Earnings
-$30.18M
Fore. Rev. Growth
-8.14%
Fore. Earn. Growth
N/A
Market Cap
$138.88M
Next Earnings
May 22, 2025
Next Dividend
N/A
PRQR Due Diligence Checks
WallStreetZen was created to help average investors do better fundamental analysis in minutes instead of hours.
Last year, PRQR revenue was $21.24M. Over the past five year, PRQR's revenue has grown by 56.45% per year. This was faster than the Biotechnology industry average of 44.31%.
No, Proqr Therapeutics Nv doesn't provide an income stream by paying out dividends.
What do other traders have to say about PRQR?
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Place your PRQR trade
There are two main types of orders:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are usually the best for newer investors.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to be sure you're buying or selling at a particular price, use a limit order.
Press the Open button and your broker will place your order.
If you want additional help investing in stocks on eToro, click the how to video below:
How much does it cost to buy one Proqr Therapeutics Nv share?
As of Apr 21, 2025, it costs $1.32 to buy one share of Proqr Therapeutics Nv stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.66, you can buy 0.5 shares of PRQR.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.